Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 9:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 1,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors
Interventions: Lenalidomide, Everolimus; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2020
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Opioid Use, Alcohol Use Disorder
Interventions: repetitive transcranial magnetic stimulation (rTMS) for AUD, repetitive transcranial magnetic stimulation (rTMS) for OUD; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Sickle Cell Disease, Vaso-occlusive Pain Episodes
Interventions: KindVR Aqua Program; Device
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 8 Years to 21 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Inflammatory Bowel Disease, Inflammatory Bowel Disease (IBD)
Interventions: Electronic medical record-based care pathway; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Not listed
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Phone Counseling, Standard Clinical Care; Behavioral · Other
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 17 Years and older
Enrollment: 762 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Breast Cancer
Interventions: Hologic Selenia Dimensions Digital Breast Tomosynthesis System; Device
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 18 Years to 110 Years · Female only
Enrollment: 3,521 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 22
States / cities: Scottsdale, Arizona • Newport Beach, California • Sacramento, California + 19 more

Conditions: Sleep Deprivation, Sleep
Interventions: 2-lead limited electroencephalography recording; Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Male only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Type 2 Diabetes
Interventions: Education + Problem-Solving Training Self-Study, Education + Group Problem-Solving Training, Education + Individual Problem-Solving Training, Usual Care; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 25 Years and older
Enrollment: 382 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Baltimore, Maryland

Conditions: Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation Failure
Interventions: Plerixafor; Drug
Lead sponsor: Hugh Taylor; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Orange, Connecticut

Conditions: Breast Cancer
Interventions: GRT (Guided Relaxation Training); Other
Lead sponsor: Trinitas Comprehensive Cancer Center; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 1
States / cities: Elizabeth, New Jersey

Conditions: Persistent Tic Disorders, Tourette Disorder
Interventions: Comprehensive Behavioral Intervention for Tics - Enhanced (CBIT-E); Behavioral
Lead sponsor: Marquette University; Other
Eligibility: 9 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
Interventions: counseling intervention, educational intervention, psychosocial assessment and care; Behavioral · Other · Procedure
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Chevy Chase, Maryland • Hackensack, New Jersey + 1 more

Conditions: Sickle Cell Disease
Interventions: SMART app; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Trauma, Sexual
Interventions: Training Intervention for the Engagement of Families (TIES); Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 7 Years to 12 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Obstructive Sleep Apnea Syndrome
Interventions: Sleep Study, Neurocognitive Testing, CBF During Wakefulness, CBF During Sleep; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 6 Years to 12 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Maternal Cardiometabolic Health, Molecular Impact of Psychological Stress and Socioeconomic Adversity, Maternal Inflammatory Markers, Maternal Diabetes, Maternal Behavior, Maternal Distress
Interventions: Mindfulness Intervention; Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Santa Ana, California

Conditions: Periprosthetic Joint Infection
Interventions: Single Debridement, Antibiotics and Implant Retention, Planned Double Debridement, Antibiotics and Implant Retention; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 490 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2032
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Telehealth, Health Behavior
Interventions: Less-is-better, Social proof, Endowment / decision staging, Standard email; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years to 88 Years
Enrollment: 14,099 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Opioid Use, Spinal Diseases, Surgery--Complications, Surgery, Postoperative Pain
Interventions: Opioid Analgesic, Opioid-Free Postoperative Pain Regimen; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Deep Venous Thrombosis
Interventions: Thrombolysis/Thrombectomy; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Metastasis, Breast Cancer
Interventions: NKTR-102, Eribulin, Ixabepilone, Vinorelbine, Gemcitabine, Paclitaxel, Docetaxel, Nab-paclitaxel; Drug
Lead sponsor: Nektar Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 19
States / cities: Tucson, Arizona • Orange, California • San Francisco, California + 16 more

Conditions: Urologic Diseases
Interventions: Stream Dx, DFree, TestCard; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Osteosarcoma
Interventions: standard of care biopsy; Other
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer, Malignant Neoplasm of Breast
Interventions: Immediate Breast Reconstruction, Delayed Breast Reconstruction, Breast-Q questionnaire; Procedure · Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 19 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Study of Everolimus (RAD001) in Combination With Lenalidomide

rTMS as Add on Treatment for Substance Use Disorders

Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain

Automated Clinical Pathway for Inflammatory Bowel Disease Care

Nurse Telephone Management of Cholesterol in Diabetes

Multicenter Hologic Tomosynthesis Study

Validation of Frontal EEG to Formal Polysomnography in the ICU

Cardiovascular Disease Education and Problem-Solving Training in People With Type 2 Diabetes

Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

Guided Relaxation Training for the Reduction of Self-Reported Stress in Individuals With Newly Diagnosed Breast Cancer

Online-Delivered Comprehensive Behavioral Intervention for Tics-Enhanced (CBIT-E)

Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions

SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge

PHF Problematic Sexual Behavior of Youth Family Engagement

Cerebral Blood Flow and Childhood Obstructive Sleep Apnea

Conscious Pregnancy: Supporting Maternal Cardiometabolic Health With Mindfulness

Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression

Email Campaign to Increase Uptake of myGeisinger

Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery

Second Line Endovascular Treatment in Acute DVT

A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine

Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.

An Organoid-based Functional Precision Medicine Trial in Osteosarcoma

Breast Reconstruction Following Breast Cancer in Very High Risk Patients